TARSUS PHARMACEUTICALS INC (TARS)

US87650L1035 - Common Stock

32.04  -0.17 (-0.53%)

After market: 32.04 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
17.45M25.82M57.03M0.000.00
Cost Of Goods
1.59M960.00K2.08MN/AN/A
Gross Profit
15.85M24.86M54.95MN/AN/A
Operating Expenses
159.01M87.57M67.10M27.00M4.29M
Research and Development
50.31M42.62M41.71M18.83M3.16M
Selling, General, and Administrative Expenses
108.70M44.95M25.40M8.17M1.14M
Operating Income
-143.16M-62.71M-12.16M-27.00M-4.29M
Interest Income/Expense
7.63M530.00K-1.54M190.00K-120.00K
Other Income/Expense
-366.00K90.00K-70.00KN/AN/A
Non Recurring Items
N/AN/AN/A0.00-260.00K
Income Before Taxes
-135.89M-62.10M-13.77M-26.81M-4.67M
Income Tax
0.000.0060.00K0.000.00
Net Income
-135.89M-62.09M-13.83M-26.81M-4.67M
EBITDA
-142.28M-62.38M-11.85M-26.90M-4.25M
 
Per Share Data
EPS Diluted Total Ops
-4.62-2.52-0.67-1.31-0.25
Non GAAP EPS
-4.64-2.55-0.68N/AN/A
 
Statistics
Gross Profit Margin
90.87%96.28%96.35%N/AN/A
Profit Margin
-778.89%-240.47%-24.25%N/AN/A
Operating Profit Margin
-820.53%-242.87%-21.32%N/AN/A

All data in USD

Charts